WashU Expert: Physician assisted death for Alzheimer’s, dementia?

As Alzheimer’s disease and other forms of dementia continue to become more prevalent, it may not be long before there is a push for legalizing physician-assisted death in dementia cases in the United States. American officials must thoroughly consider the moral and social consequences of such an action, says an expert on medical ethics at Washington University in St. Louis.
Liviu Mirica

Longer-lived imaging agents could hasten Alzheimer’s research

A chemist at Washington University in St. Louis hopes to develop bifunctional compounds that can be both therapeutic and diagnostic agents for Alzheimer’s disease. In the first role, they would block the metal-mediated formation of amyloid beta oligomers; in the second, they would be loaded with a long-lived radioistope (Cu-64) and employed as PET imaging agents.
Older Stories